Omeros Corporation Company Profile (NASDAQ:OMER)

Analyst Ratings

Consensus Ratings for Omeros Corporation (NASDAQ:OMER) (?)
Ratings Breakdown: 9 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $41.25 (276.03% upside)

Analysts' Ratings History for Omeros Corporation (NASDAQ:OMER)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2016FBR & CoReiterated RatingOutperform$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/14/2016WBB SecuritiesReiterated RatingBuy$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2016Maxim GroupInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2016Cantor FitzgeraldInitiated CoverageBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016WedbushReiterated RatingOutperform$62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2016Needham & Company LLCLower Price TargetBuy$30.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2015Roth CapitalReiterated RatingBuy$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2015Cowen and CompanyReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015MLV & Co.Reiterated RatingBuy$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Omeros Corporation (NASDAQ:OMER)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/10/2016Q116($0.43)($0.54)$8.79 million$7.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q415($0.53)($0.52)$5.35 million$6.66 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q315($0.47)($0.46)$7.97 million$3.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.56)($0.44)$2.86 million$3.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q115($0.63)($0.51)$0.15 million$0.39 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/16/2015Q4($0.62)($0.61)$0.15 million$0.18 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q114($0.59)($0.54)$0.43 million$0.21 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014Q2($0.56)($0.53)$0.37 million$0.45 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014Q1($0.45)($0.45)$0.45 million$0.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2014Q413($0.38)($0.05)$0.17 million$1.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313($0.44)($0.46)$0.14 million$0.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/9/2013Q213($0.38)($0.48)$1.19 million$0.14 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/10/2013Q1 2013($0.39)($0.40)$1.39 million$1.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/18/2013($0.35)($0.30)$1.49 million$1.58 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2012Q312($0.34)($0.51)$1.42 million$1.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012($0.36)($0.38)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2011($0.39)($0.29)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Omeros Corporation (NASDAQ:OMER)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.52)($0.42)($0.47)
Q2 20163($0.52)($0.31)($0.43)
Q3 20163($0.47)($0.22)($0.36)
Q4 20163($0.40)($0.12)($0.30)
Q1 20171($0.32)($0.32)($0.32)
Q2 20171($0.20)($0.20)($0.20)
Q3 20171($0.05)($0.05)($0.05)
Q4 20171$0.12$0.12$0.12
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Omeros Corporation (NASDAQ:OMER)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Omeros Corporation (NASDAQ:OMER)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/15/2016Marcia S KelbonVPSell15,900$11.50$182,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2016Marcia S KelbonVPSell15,900$11.42$181,578.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Marcia S KelbonVPSell15,900$9.94$158,046.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2016Marcia S KelbonVPSell15,900$15.18$241,362.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2016Thomas J CableDirectorSell2,000$14.81$29,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2015Marcia S. KelbonVPSell15,900$15.00$238,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2015Peter A Md DemopulosDirectorBuy3,962$12.68$50,238.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015Thomas J CableDirectorSell2,000$18.78$37,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2015Thomas J CableDirectorSell2,000$24.50$49,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2014Peter A Md DemopulosDirectorBuy6,153$16.20$99,678.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Thomas J CableDirectorSell5,000$11.80$59,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/3/2013Thomas J CableDirectorSell5,000$5.21$26,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2013Thomas J CableDirectorSell5,000$3.98$19,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2013Ray AspiriDirectorBuy40,000$5.72$228,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/3/2013Arnold C HanishDirectorBuy2,000$5.58$11,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Omeros Corporation (NASDAQ:OMER)
DateHeadline
07/23/16 09:33 AMShares Stumbling of Late: Omeros Corporation (NASDAQ:OMER) - TGP
07/23/16 09:33 AMStock Displaying Signs of a Downtrend: Omeros Corporation (NASDAQ:OMER) - Press Telegraph
07/21/16 05:57 PMOmeros Corporation (NASDAQ:OMER): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/20/16 06:23 PMEquity Roundup: Stock Performance Focus on Omeros Corporation (NASDAQ:OMER) - Press Telegraph
07/20/16 06:23 PMOmeros Corporation (OMER) Drops 6.96% on July 19 - Equities.com
07/20/16 07:18 AMOmeros Corp. breached its 50 day moving average in a Bearish Manner : OMER-US : July 20, 2016 -
07/19/16 07:00 AMEarnings Focus and Crowd Sourced Sentiment Review for Omeros Corporation (NASDAQ:OMER) - TGP
07/17/16 09:51 AMVP Patent and General Counsel of Omeros Corporation (NASDAQ:OMER), Kelbon Marcia S., sells 15,900 shares worth $182,804
07/16/16 05:10 PMFEI Announces 2016 Hall of Fame Inductees
07/16/16 08:56 AMShares Experiencing a Downtrend: Omeros Corporation (NASDAQ:OMER) - TGP
07/16/16 08:56 AMWere Analysts Bullish Omeros Corporation (NASDAQ:OMER) This Week? - Consumer Eagle
07/15/16 10:37 AMOmeros Corporation (OMER) Drops 7.52% on July 13 - Equities.com
07/14/16 09:13 AMAnalyst Target and Average Rating Watch: Omeros Corporation (NASDAQ:OMER) - Press Telegraph
07/14/16 09:13 AMOmeros Corporation (OMER) is Trading Higher on Unusual Volume for July 12 - Equities.com
07/12/16 09:57 AMTop News: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Omeros Corporation (NASDAQ:OMER), Dick's Sporting Goods ... - KC Register
07/12/16 09:57 AMOmeros Corporation (NASDAQ:OMER) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/12/16 09:57 AMOmeros Corporation (NASDAQ:OMER) Sellers Increased By 0.9% Their Shorts - Consumer Eagle
07/09/16 05:02 PMHow Many Omeros Corporation (NASDAQ:OMER)'s Analysts Are Bullish? - Press Telegraph
07/08/16 08:36 AMCan Omeros Corporation (NASDAQ:OMER) Improve on the Earnings Front? - Engelwood Daily
07/08/16 08:36 AMCompany Stock Focus for Omeros Corporation (NASDAQ:OMER): Which Way Will Shares Head? - Press Telegraph
07/08/16 08:36 AMOmeros Corporation (OMER) is Trading Higher on Unusual Volume for July 05 - Equities.com
07/07/16 05:41 PMOmeros Corporation : Announces Completion of Patient Enrollment in Pediatric Trial of OMIDRIA®
07/07/16 06:21 AMOmeros to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference - [at noodls] - SEATTLE--(BUSINESS WIRE)--Jul. 7, 2016-- Omeros Corporation (NASDAQ:OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics ...
07/06/16 10:14 AMStock Tracking Down This Month; Investor Alert on Omeros Corporation (NASDAQ:OMER) - Engelwood Daily
07/06/16 10:14 AMOmeros Corporation (OMER) Jumps 6.75% on July 04 - Equities.com
07/06/16 07:06 AMOmeros Corp. breached its 50 day moving average in a Bullish Manner : OMER-US : July 6, 2016 -
07/05/16 05:23 PMCould Omeros Corporation Decrease Even More? The Stock Formed Double Bottom Pattern - Press Telegraph
07/05/16 05:23 PMAcme United Corp. (NYSEMKT:ACU) Rose 3.50%: Omeros Corporation (NASDAQ:OMER), Atwood Oceanics, Inc ... - KC Register
07/04/16 04:55 PMShare Performance Recap for: Omeros Corporation (NASDAQ:OMER) - Press Telegraph
07/03/16 09:51 AMWill Omeros Corporation (NASDAQ:OMER) Surprise Analysts? - Investor Newswire
07/03/16 09:51 AMRecently Issued Stock Ratings For Omeros Corporation (OMER) - Fiscal Standard
07/03/16 09:51 AMOmeros: Major Upside Ahead For This Small Biotech - Seeking Alpha
07/02/16 05:16 PMOmeros: Major Upside Ahead For This Small Biotech
07/01/16 05:40 PMOmeros completes patient enrollment in pediatric trial of OMIDRIA
06/30/16 05:55 PMExpect OraSure To Drop 35% (Or More) Next Week
06/30/16 11:26 AMETF’s with exposure to Omeros Corp. : June 30, 2016 -
06/29/16 08:29 AMCould Omeros Corporation Decline After Today's Huge Increase? - Engelwood Daily
06/29/16 06:00 AMOmeros Corporation Announces Completion of Patient Enrollment in Pediatric Trial of OMIDRIA® - [Business Wire] - Omeros Corporation , a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced that it has completed enrollment in the post-marketing pediatric clinical trial that is expected to provide ...
06/28/16 05:36 PMReport delivers insight into the hepatocellular carcinoma pipeline landscape and therapeutics under development ... - WhaTech
06/25/16 09:20 AMOmeros Corporation (OMER) Updated Price Targets - FTSE News
06/24/16 08:12 AMGlobal Hypercholesterolemia Pipeline Report 2016 - Therapeutics Review of 36 Companies & Drug Profile Activity - Research and Markets
06/20/16 07:15 AMOmeros Corporation (OMER) Analyst Price Targets For The Coming Week - Fiscal Standard
06/17/16 05:26 PMGlobal Diabetic Neuropathy Therapeutics Pipeline Review 2016 - Research and Markets
06/15/16 05:35 PMAnalysts Have Conflicting Sentiments on These Healthcare Companies: Omeros (NASDAQ: OMER) and Infinity ... - Markets.co
06/13/16 08:45 AMSeattle biotech outpaces Washington's public companies -
06/10/16 03:17 PMOMEROS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/08/16 06:02 PMOmeros Corporation (NASDAQ:OMER) plummeted -8.01%: Horizon Pharma plc (NASDAQ:HZNP), MannKind Corp ... - KC Register
06/08/16 01:26 PMETF’s with exposure to Omeros Corp. : June 8, 2016 -
06/08/16 08:37 AMHealthcare Losers: Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Catalent, Inc. (NYSE:CTLT), CytRx Corporation ... - KC Register
06/06/16 09:18 AMOmeros Corporation (OMER) Broker Price Targets For The Coming Week - Share Trading News

Social

About Omeros Corporation

Omeros Corporation logoOmeros Corporation is a biopharmaceutical company engaged in discovering, developing and commercializing small-molecule and protein therapeutics for market, as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's marketed drug product, Omidria (phenylephrine and ketorolac injection), is used during cataract surgery or intraocular lens replacement. Its clinical programs include Mannan-binding lectin-associated serine protease-2 (MASP-2) (OMS721)-Lectin Pathway Disorders; PDE10 (OMS824)-CNS Disorders; peroxisome proliferator-activated receptor gamma (PPARy) (OMS405)-Addiction, and OMS201-Urology. Its preclinical programs include phosphodiesterase 7 (PDE7) (OMS527), Plasmin (OMS616), MASP-3 (OMS906)-Alternative Pathway Disorders, GPR17-CNS Disorders, GPR101-Metabolic Disorders, GPR151-CNS Disorders, GPR161-Cancer, GPR174-Immune Disorders, GPR183-Skeletal and Infectious Diseases, GPCR Platform and Antibody Platform.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: OMER
  • CUSIP: 68214310
Key Metrics:
  • Previous Close: $10.97
  • 50 Day Moving Average: $11.00
  • 200 Day Moving Average: $12.09
  • P/E Ratio: N/A
  • P/E Growth: -0.07
  • Market Cap: $429.31M
  • Beta: 2.15
  • Current Year EPS Consensus Estimate: $-1.72 EPS
  • Next Year EPS Consensus Estimate: $-0.34 EPS
Additional Links:
Omeros Corporation (NASDAQ:OMER) Chart for Wednesday, July, 27, 2016